Pramlintide: A Novel Therapeutic Approach for Osteosarcoma through Metabolic Reprogramming

SIMPLE SUMMARY: Outcomes for patients with osteosarcoma have remained stagnant for more than 3 decades. Novel therapeutic agents are desperately needed. Osteosarcoma cells often express abnormal form of the p53, p63, and p73 genes, which promote glucose uptake, cell glycolysis, and rapid proliferati...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yuanzheng, Peng, Zhanglong, Flores, Elsa R., Kleinerman, Eugenie S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454976/
https://www.ncbi.nlm.nih.gov/pubmed/36077845
http://dx.doi.org/10.3390/cancers14174310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454976/
https://www.ncbi.nlm.nih.gov/pubmed/36077845
http://dx.doi.org/10.3390/cancers14174310

Ejemplares similares